SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Cannabis > Cannabix Technologies Inc. (BLOZF)

Cannabix is developing its FAIMS- (field asymmetric waveform

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
FreezeThese Member Profile
 
Followed By 46
Posts 4,213
Boards Moderated 4
Alias Born 03/25/15
160x600 placeholder
FreezeThese   Thursday, 05/25/17 08:41:48 AM
Re: None
Post # of 19315 
Cannabix is developing its FAIMS- (field asymmetric waveform ion mobility spectrometry) based marijuana breathalyzer for the detection of delta-9-tetrahydrocannabinol ("THC") in human breath. The addition of Dr. Hasman to our Florida-Vancouver scientific team, will broaden our testing capabilities in Vancouver with human subjects using the Cannabix Marijuana Breathalyzer Beta prototype. The Company is substantially increasing its testing ability with new equipment and staff joining the Vancouver operation. Over the last several weeks, the Company has been developing a new front end breath intake system and calibrating decay signal intensities.

Dr. Raj Attariwala, commented, "We are excited to have Dr. Hasman join our Vancouver team as we prepare for trials using the patented FAIMS device with court accepted techniques of mass spectroscopy. His expertise in toxicology and forensic mass spec have been instrumental with government toxicology labs during the recent fentanyl crisis in BC and his skills will be invaluable as we prepare for trials with the Cannabix marijuana breathalyzer device."


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist